https://helveticmarkets.com/en/article/the-swiss-franc-shock-when-a-central-bank-move-wiped-out-brokers Helvetic Markets en 2026-10-06T07:00:00+00:00 The Swiss Franc Shock: When a Central Bank Move Wiped Out Brokers https://helveticmarkets.com/en/article/why-classic-dividend-aristocrats-losing-ground-compounders Helvetic Markets en 2026-10-06T06:00:00+00:00 Why classic dividend aristocrats are losing ground to compounders https://helveticmarkets.com/en/article/frankfurt-stocks-stagnate-as-investors-remain-cautious Helvetic Markets en 2026-10-06T06:00:00+00:00 Frankfurt Stocks Stagnate as Investors Remain Cautious https://helveticmarkets.com/en/article/france-germany-propose-new-eu-trade-tool-counter-china Helvetic Markets en 2026-10-06T06:00:00+00:00 France and Germany propose new EU trade tool to counter China https://helveticmarkets.com/en/article/banque-richelieu-switzerland-appoints-richard-albrecht-new Helvetic Markets en 2026-10-05T16:00:00+00:00 Banque Richelieu Switzerland Appoints Richard Albrecht as New CEO https://helveticmarkets.com/de/article/banque-richelieu-switzerland-appoints-richard-albrecht-new Helvetic Markets de 2026-10-05T16:00:00+00:00 Banque Richelieu Switzerland ernennt Richard Albrecht zum neuen CEO https://helveticmarkets.com/fr/article/banque-richelieu-switzerland-appoints-richard-albrecht-new Helvetic Markets fr 2026-10-05T16:00:00+00:00 Banque Richelieu Switzerland nomme Richard Albrecht nouveau CEO https://helveticmarkets.com/en/article/ecb-executive-board-member-lane-discusses-monetary-policy Helvetic Markets en 2026-10-05T11:00:00+00:00 ECB Executive Board Member Lane Discusses Monetary Policy Diagnostic Challenges https://helveticmarkets.com/de/article/ecb-executive-board-member-lane-discusses-monetary-policy Helvetic Markets de 2026-10-05T11:00:00+00:00 EZB-Direktoriumsmitglied Lane erörtert diagnostische Herausforderungen der Geldpolitik https://helveticmarkets.com/fr/article/ecb-executive-board-member-lane-discusses-monetary-policy Helvetic Markets fr 2026-10-05T11:00:00+00:00 Lane, membre du directoire de la BCE, examine les défis du diagnostic en matière de politique monétaire https://helveticmarkets.com/en/article/dws-agrees-acquire-real-estate-manager-peakside-capital Helvetic Markets en 2026-10-05T11:00:00+00:00 DWS Agrees to Acquire Real Estate Manager Peakside Capital Advisors https://helveticmarkets.com/de/article/dws-agrees-acquire-real-estate-manager-peakside-capital Helvetic Markets de 2026-10-05T11:00:00+00:00 DWS vereinbart Übernahme des Immobilienmanagers Peakside Capital Advisors https://helveticmarkets.com/fr/article/dws-agrees-acquire-real-estate-manager-peakside-capital Helvetic Markets fr 2026-10-05T11:00:00+00:00 DWS conclut un accord pour acquérir le gestionnaire immobilier Peakside Capital Advisors https://helveticmarkets.com/en/article/mario-draghi-addresses-swiss-national-bank-lecture-in-zurich Helvetic Markets en 2026-10-05T06:00:00+00:00 Mario Draghi Addresses Swiss National Bank Lecture in Zurich https://helveticmarkets.com/de/article/mario-draghi-addresses-swiss-national-bank-lecture-in-zurich Helvetic Markets de 2026-10-05T06:00:00+00:00 Mario Draghi spricht bei Vortragsveranstaltung der Schweizerischen Nationalbank in Zürich https://helveticmarkets.com/fr/article/mario-draghi-addresses-swiss-national-bank-lecture-in-zurich Helvetic Markets fr 2026-10-05T06:00:00+00:00 Mario Draghi intervient lors d’une conférence de la Banque nationale suisse à Zurich https://helveticmarkets.com/en/article/bmw-volkswagen-pursue-overhauls-revive-slumping Helvetic Markets en 2026-10-04T14:00:00+00:00 BMW and Volkswagen Pursue Overhauls to Revive Slumping Profitability https://helveticmarkets.com/de/article/bmw-volkswagen-pursue-overhauls-revive-slumping Helvetic Markets de 2026-10-04T14:00:00+00:00 BMW und Volkswagen setzen auf umfassenden Umbau zur Wiederbelebung der schwächelnden Rentabilität https://helveticmarkets.com/fr/article/bmw-volkswagen-pursue-overhauls-revive-slumping Helvetic Markets fr 2026-10-04T14:00:00+00:00 BMW et Volkswagen engagent des restructurations pour redresser leur rentabilité en recul https://helveticmarkets.com/en/article/why-biogen-novartis-nurexone-target-orphan-drug-pathway Helvetic Markets en 2026-10-04T11:00:00+00:00 Why Biogen, Novartis and NurExone Target the Orphan Drug Pathway https://helveticmarkets.com/de/article/why-biogen-novartis-nurexone-target-orphan-drug-pathway Helvetic Markets de 2026-10-04T11:00:00+00:00 Warum Biogen, Novartis und NurExone auf den Orphan-Drug-Pfad setzen https://helveticmarkets.com/fr/article/why-biogen-novartis-nurexone-target-orphan-drug-pathway Helvetic Markets fr 2026-10-04T11:00:00+00:00 Pourquoi Biogen, Novartis et NurExone misent sur la voie des médicaments orphelins https://helveticmarkets.com/en/article/swiss-firms-rely-traditional-patterns-board-appointments Helvetic Markets en 2026-10-04T11:00:00+00:00 Swiss firms rely on traditional patterns for board appointments https://helveticmarkets.com/de/article/swiss-firms-rely-traditional-patterns-board-appointments Helvetic Markets de 2026-10-04T11:00:00+00:00 Schweizer Unternehmen setzen bei Verwaltungsratsbesetzungen auf traditionelle Muster https://helveticmarkets.com/fr/article/swiss-firms-rely-traditional-patterns-board-appointments Helvetic Markets fr 2026-10-04T11:00:00+00:00 Les entreprises suisses privilégient les schémas traditionnels pour les nominations aux conseils d'administration